Date Draft Aims to Gamify Ghosting with Revolutionary “Trade Room” Feature – Shifts Launch to January 2026 for Enhanced User Experience GlobeNewswire December 02, 2025 WASHINGTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — Date Draft, a new mobile dating app launching in January 2026, is tackling one of the digital dating world's most pervasive problems–ghosting–by turning […]

Charli Brings High-Assurance AI to Capital Markets; Unveils Governance Blueprint and Q4 Platform Expansion Building on the success of InvestorEdge, the company confirms Q4 release of IssuerEdge and DeveloperEdge, establishing a unified “Blueprint for Governance” across the financial sector. GlobeNewswire December 02, 2025 VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — Charli, the AI

Applied Digital Leads $25 Million Funding Round for Corintis to Advance Innovation in Data Center Technology Investment underscores Applied Digital's strategy to accelerate its leadership in high-performance, AI-optimized data centers through partnerships that advance power, cooling, and efficiency GlobeNewswire December 02, 2025 DALLAS, Dec. 02, 2025 (GLOBE NEWSWIRE) — Applied Digital (NASDAQ: APLD) a designer,

Electra Therapeutics Presents SURPASS Pivotal ELA026 Study Design and Highlights the Critical Unmet Need in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) at the ASH 2025 Annual Meeting GlobeNewswire December 02, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) — Electra Therapeutics, a clinical stage biotechnology company pioneering therapies against novel targets for diseases in immunology

Marex Group plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – MRX GlobeNewswire December 02, 2025 LOS ANGELES, Dec. 02, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Marex Group plc (“Marex” or “the Company”) (NASDAQ: MRX) for violations

Rocket Doctor AI Announces Strong Q3 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth GlobeNewswire December 02, 2025 Continued organic quarter over quarter revenue growth despite expected summer seasonality Earnings per share for Q3, 2025: ($0.05) per share. Oversubscribed raise of C$4.23m contributing to significantly improved cash position. Announced signed in-network contracts

Apollo to Present at the Goldman Sachs 2025 US Financial Services Conference GlobeNewswire December 02, 2025 NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Marc Rowan, Chief Executive Officer and Chair of the board of Apollo, will participate in a fireside chat at the Goldman Sachs US Financial Services

Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership GlobeNewswire December 02, 2025 MORRISVILLE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) — Science 37, the leader in expanding patient access to clinical trials, today announced that it has been awarded the Research and Development – Site Innovation honor in the 2025 Clinical

Sweet Harvest Foods' Apiary Nate's Hives Becomes America's Largest Beekeeper Now Operating More Than 120,000 Honey Bee Colonies Five acquisitions over three years by Nate's Hives position the operating company of Nate's Honey at the forefront of U.S. honey production and innovation while preserving local beekeeping expertise GlobeNewswire December 02, 2025 CANNON FALLS, Minn., Dec.

Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire December 02, 2025 DURHAM, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced that Pelthos' CEO Scott Plesha will participate in a